90/014,328GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS7,935,365Closed

Status

Reexamination Certificate Issued

Filed

Jun 28, 2019

Last Updated

Apr 8, 2020

Art Unit

3991

Requester

Unknown

Requester Law Firm

Unknown

Requested By

Third Party

Patent OwnerInferred

Enzymotec Ltd.

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

424Drug, Bio-Affecting And Body Treating Compositions

Reexam History (34 events)

Apr 9, 2020CCRDYApplication ready for PDX access by participating foreign offices
Apr 8, 2020REEXInput Issue Number and Issue Date for Reexamination
Mar 23, 2020RXPUBSReexam Forwarded to Office of Publications
Mar 20, 2020MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Feb 27, 2020RXC/SRCertificate of Service
Feb 27, 2020RXAAF.Response to Final Filed (or Ready for Examiner Action)
Feb 10, 2020RXLITSRReexam Litigation Search Conducted
Jan 17, 2020MRXFRRX - Mail Final Rejection
Dec 19, 2019PA..Change in Power of Attorney (May Include Associate POA)
Dec 19, 2019C.ADCorrespondence Address Change
Dec 17, 2019RXC/SRCertificate of Service
Dec 17, 2019RXA...Response after Non-Final Action
Oct 25, 2019MR.NFRX - Mail Reexam Non-Final Action
Oct 10, 2019RXFWDXDate Forwarded to Examiner
Sep 10, 2019NRX.Notice of Reexam Published in Official Gazette
Aug 7, 2019MREXORX - Mail Ex Parte Request for Reexamination Granted
Jul 23, 2019IDSCInformation Disclosure Statement considered
Jul 22, 2019DOCKCase Docketed to Examiner in GAU
Jul 18, 2019RXLITSRReexam Litigation Search Conducted
Jul 12, 2019MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Jul 11, 2019RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Jul 11, 2019RXNREQFDNotice of reexamination request filing date
Jul 11, 2019RXNREQAUNotice of assignment of reexamination request
Jul 11, 2019MRXNReexamination Formalities Notice Mailed
Jul 11, 2019MRXNReexamination Formalities Notice Mailed
Jul 11, 2019FTFIFITF set to NO - revise initial setting
Jul 9, 2019PRXRParalegal Reexam Review Complete
Jun 28, 2019WIDSInformation Disclosure Statement (IDS) Filed
Jun 28, 2019SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Jun 28, 2019RXTTLRPTTitle Report
Jun 28, 2019RXOSUBReceipt of Original Ex Parte Reexam Request
Jun 28, 2019RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Jun 28, 2019RXIDS.Information Disclosure Statement Filed
Jun 28, 2019BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedFeb 3, 2011

Prosecution History

DateCodeDescription
Feb 7, 2011P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Feb 3, 2011DISTTerminal Disclaimer Filed
Oct 20, 2010P575Paralegal TD Not accepted
Oct 6, 2010DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
May 3, 2011
3.5-yr
Nov 3, 2014
7.5-yr
Nov 3, 2018
Paid Oct 31, 2018
11.5-yr
Nov 3, 2022
Paid Oct 19, 2022
Expiry
Oct 21, 2028

Entity Status

Large Entity

Expires

Oct 21, 2028 (2.6 yr remaining)

Term Adjustment

+119 days (~0.3 yr)

Assignments

200920102011FiledAVIDOR SHULMANDORI PELLEDZOHAR BAR-ONYAEL RICHTERDORIT PLATTGAI BEN DRORORLY FARKASHRASSAN ZUABIENZYMOTEC, INC.ENZYMOTEC LTD.
AssignmentReel/Frame: 022146/0718Recorded: Jan 21, 2009

From

ZOHAR BAR-ONInventor
Nov 26, 2008
GAI BEN DRORInventor
Dec 9, 2008
ORLY FARKASHInventor
Dec 10, 2008
DORI PELLEDInventor
Nov 13, 2008
DORIT PLATTInventor
Dec 7, 2008
YAEL RICHTERInventor
Dec 3, 2008
AVIDOR SHULMANInventor
Nov 11, 2008
RASSAN ZUABIInventor
Dec 14, 2008

To

ENZYMOTEC, INC.

OtherReel/Frame: 025771/0721Recorded: Feb 8, 2011

From

ENZYMOTEC LTD
Feb 8, 2011

To

ENZYMOTEC LTD.